Paragon 28 Completes First Quarter as Public Company

Paragon 28 reported 3Q21 orthopedic sales of $35.9 million, +18.4% vs. 3Q20. This quarter marked the company's first as a public company after its recent IPO raised $131 million in net proceeds. Going public has helped reduce hesitation from potential new sales reps who feared joining Paragon 28 only for the company to be acquired by one of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us